Freeman Foundation For Neurological Disease Research (FFNDR) Founder Tim Freeman grew up in Junction, TX where he graduated high school in 1982. From there, Tim attended The University of Texas at Austin and was a walk-on football player for the Longhorns for 2.5 years.
Tim has been selling medical devices for 27 years. During his time with Medtronic, they came out with their first generation Deep Brain Stimulation (DBS) device. As the Image-Guided Surgery Specialist, Freeman was involved in some of the first DBS implants in Houston. This was only the beginning of Tim’s path with Parkinson’s. Just two short years later, Tim’s mother, Beth Freeman, would be diagnosed with Parkinson’s Disease. In 2007, Mrs. Freeman lost her battle with Parkinson’s at the age of 71. Just five years later, at the age of 49, after competing in a 100-mile bicycle race in New York, Tim was back in Junction for graduation ceremonies where he was awarding scholarships. During the presentations, he noticed a tremor in his right hand, but not in his left hand. He knew at that point that he had a serious problem and immediately went to a neurologist in Houston. In June 2013, Tim was diagnosed with Parkinson’s Disease.
Tim Freeman shared, “My immediate reaction was that it’s impossible, PD is an old person disease, and at this time I was in prime physical condition. I was uncertain how long I had to live, etc., and from the 45 minutes I had to drive from The Medical Center to The Woodlands, I had my pity party. When I got home, I wrote a letter to friends and family about the news. In conclusion, I told everyone not to be worried because PD had picked the wrong person to mess with and that we will defeat it!”
After years of hosting events to spread awareness about Parkinson’s Disease and raising funds to support Team Fox and The Michael J. Fox Foundation, Tim decided to launch the Freeman Foundation for Neurological Disease Research in April 2019. The Freeman Foundation For Neurological Disease Research is a 501(c)3 nonprofit organization dedicated to accelerating breakthrough research and supporting innovative scientific investigations for neurological brain disorders.